Solventum (NYSE:SOLV – Get Free Report) and Anteris Technologies Global (NASDAQ:AVR – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.
Valuation and Earnings
This table compares Solventum and Anteris Technologies Global”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Solventum | $8.32 billion | 1.87 | $1.56 billion | $8.18 | 11.21 |
| Anteris Technologies Global | $1.91 million | 461.28 | -$94.14 million | ($1.95) | -4.64 |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Solventum and Anteris Technologies Global, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solventum | 1 | 4 | 8 | 0 | 2.54 |
| Anteris Technologies Global | 1 | 0 | 4 | 0 | 2.60 |
Solventum currently has a consensus target price of $91.64, indicating a potential downside of 0.07%. Anteris Technologies Global has a consensus target price of $16.00, indicating a potential upside of 76.99%. Given Anteris Technologies Global’s stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Solventum.
Profitability
This table compares Solventum and Anteris Technologies Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solventum | 17.26% | 25.09% | 8.78% |
| Anteris Technologies Global | -4,619.27% | -77.69% | -67.99% |
Volatility and Risk
Solventum has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Anteris Technologies Global has a beta of 1.8, suggesting that its share price is 80% more volatile than the S&P 500.
Summary
Solventum beats Anteris Technologies Global on 8 of the 12 factors compared between the two stocks.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.
